156 related articles for article (PubMed ID: 8165385)
41. I couldn't sleep at all last night.
Young DK
J Clin Sleep Med; 2005 Jan; 1(1):95-6. PubMed ID: 17561620
[No Abstract] [Full Text] [Related]
42. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial.
Stiasny K; Röbbecke J; Schüler P; Oertel WH
Sleep; 2000 May; 23(3):349-54. PubMed ID: 10811379
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
[TBL] [Abstract][Full Text] [Related]
44. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
Stiasny-Kolster K; Oertel WH
Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023
[TBL] [Abstract][Full Text] [Related]
45. The validity of the PAM-RL device for evaluating periodic limb movements in sleep and an investigation on night-to-night variability of periodic limb movements during sleep in patients with restless legs syndrome or periodic limb movement disorder using this system.
Kobayashi M; Namba K; Ito E; Nishida S; Nakamura M; Ueki Y; Furudate N; Kagimura T; Usui A; Inoue Y
Sleep Med; 2014 Jan; 15(1):138-43. PubMed ID: 24269130
[TBL] [Abstract][Full Text] [Related]
46. A controlled trial of levodopa plus carbidopa in the treatment of winter seasonal affective disorder: a test of the dopamine hypothesis.
Oren DA; Moul DE; Schwartz PJ; Wehr TA; Rosenthal NE
J Clin Psychopharmacol; 1994 Jun; 14(3):196-200. PubMed ID: 8027416
[TBL] [Abstract][Full Text] [Related]
47. Double-Blind, Placebo-Controlled, Randomized Phase I/IIa Study (Safety and Efficacy) with Buspirone/Levodopa/Carbidopa (SpinalonTM) in Subjects with Complete AIS A or Motor-Complete AIS B Spinal Cord Injury.
Radhakrishna M; Steuer I; Prince F; Roberts M; Mongeon D; Kia M; Dyck S; Matte G; Vaillancourt M; Guertin PA
Curr Pharm Des; 2017; 23(12):1789-1804. PubMed ID: 28025945
[TBL] [Abstract][Full Text] [Related]
48. Pathological yawning (chasm) associated with periodic leg movements in sleep: cure by levodopa.
Leonhardt M; Abele M; Klockgether T; Dichgans J; Weller M
J Neurol; 1999 Jul; 246(7):621-2. PubMed ID: 10463371
[No Abstract] [Full Text] [Related]
49. Levodopa-carbidopa and childhood retinal disease.
Leguire LE; Jende DL; Nairus TM; Walson PD; Rogers GL; Bremer DL; McGregor ML
J AAPOS; 1998 Apr; 2(2):79-85. PubMed ID: 10530967
[TBL] [Abstract][Full Text] [Related]
50. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
Fahn S;
J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
[TBL] [Abstract][Full Text] [Related]
51. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
52. Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.
Simpson GM; Yadalam KG; Stephanos MJ
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):49S-51S. PubMed ID: 2906069
[TBL] [Abstract][Full Text] [Related]
53. Randomized, Double-Blind, Placebo-Controlled Study of Clonidine in Restless Legs Syndrome.
Wagner ML; Walters AS; Coleman RG; Hening WA; Grasing K; Chokroverty S
Sleep; 1996 Jan; 19(1):52-8. PubMed ID: 8650464
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off.
Kuoppamäki M; Leinonen M; Poewe W
J Neural Transm (Vienna); 2015 Dec; 122(12):1709-14. PubMed ID: 26347184
[TBL] [Abstract][Full Text] [Related]
55. Longitudinal study of levodopa/carbidopa for childhood amblyopia.
Leguire LE; Walson PD; Rogers GL; Bremer DL; McGregor ML
J Pediatr Ophthalmol Strabismus; 1993; 30(6):354-60. PubMed ID: 8120739
[TBL] [Abstract][Full Text] [Related]
56. Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease.
Hauser RA; Ellenbogen AL; Metman LV; Hsu A; O'Connell MJ; Modi NB; Yao HM; Kell SH; Gupta SK
Mov Disord; 2011 Oct; 26(12):2246-52. PubMed ID: 21755537
[TBL] [Abstract][Full Text] [Related]
57. New actigraphic assessment method for periodic leg movements (PLM).
Kazenwadel J; Pollmächer T; Trenkwalder C; Oertel WH; Kohnen R; Künzel M; Krüger HP
Sleep; 1995 Oct; 18(8):689-97. PubMed ID: 8560136
[TBL] [Abstract][Full Text] [Related]
58. Levodopa-carbidopa may improve vision loss in indirect traumatic optic neuropathy.
Razeghinejad MR; Rahat F; Bagheri M
J Neurotrauma; 2010 Oct; 27(10):1905-9. PubMed ID: 20649490
[TBL] [Abstract][Full Text] [Related]
59. Periodic leg movements in RLS patients as compared to controls: Are there differences beyond the PLM index?
Boehm G; Wetter TC; Trenkwalder C
Sleep Med; 2009 May; 10(5):566-71. PubMed ID: 18753004
[TBL] [Abstract][Full Text] [Related]
60. Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial.
Bassetti CL; Bornatico F; Fuhr P; Schwander J; Kallweit U; Mathis J;
Swiss Med Wkly; 2011; 141():w13274. PubMed ID: 22101745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
